XML 19 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Assets:    
Cash and due from banks $ 85,409 $ 81,626
Cash at Federal Reserve and other banks 59,547 17,075
Cash and cash equivalents 144,956 98,701
Investment securities:    
Marketable equity securities 2,609 2,634
Available for sale debt securities, at fair value (amortized cost of $2,138,533 and $2,384,325) 1,904,885 2,152,504
Held to maturity debt securities, at amortized cost, net of allowance for credit losses of $0 111,866 133,494
Restricted equity securities 17,250 17,250
Loans held for sale 709 458
Loans 6,768,523 6,794,470
Allowance for credit losses (125,366) (121,522)
Total loans, net 6,643,157 6,672,948
Premises and equipment, net 70,287 71,347
Cash value of life insurance 140,149 136,892
Accrued interest receivable 34,810 36,768
Goodwill 304,442 304,442
Other intangible assets, net 6,432 10,552
Operating leases, right-of-use 23,529 26,133
Other assets 268,647 245,966
Total assets 9,673,728 9,910,089
Deposits:    
Noninterest-bearing demand 2,548,613 2,722,689
Interest-bearing 5,538,963 5,111,349
Total deposits 8,087,576 7,834,038
Accrued interest payable 11,501 8,445
Operating lease liability 25,437 28,261
Other liabilities 137,506 145,982
Other borrowings 89,610 632,582
Junior subordinated debt 101,191 101,099
Total liabilities 8,452,821 8,750,407
Commitments and contingencies (Note 15)
Shareholders’ equity:    
Preferred stock, no par value: 1,000,000 shares authorized; zero issued and outstanding at December 31, 2024 and 2023, respectively 0 0
Common stock, 0 par value: 50,000,000 shares authorized; issued and outstanding: 32,970,425 and 33,268,102 at December 31, 2024 and 2023, respectively 693,462 697,349
Retained earnings 679,907 615,502
Accumulated other comprehensive loss, net of tax (152,462) (153,169)
Total shareholders’ equity 1,220,907 1,159,682
Total liabilities and shareholders’ equity $ 9,673,728 $ 9,910,089